As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are ...
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on ...
ET Now on MSN
Exclusive | Dr Reddy's USFDA 5 observations from Srikakulam plant: Details from Form 483
Dr Reddy's Laboratories informed the stock exchanges on December 12, 2025, about the conclusion of the inspection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback